Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

BACKGROUND: Abnormal autocrine fibroblast growth factor 19 (FGF19) production has been observed in several types of cancers, including hepatocellular carcinoma (HCC). In this study, we investigated the potential of serum FGF19 as a novel tumor marker of HCC based on a sandwich enzyme-linked immunoso...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Takahiro, Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Kanayama, Kengo, Maruta, Susumu, Kusakabe, Yuko, Saito, Tomoko, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Nakagawa, Ryo, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849282/
https://www.ncbi.nlm.nih.gov/pubmed/31718608
http://dx.doi.org/10.1186/s12885-019-6322-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849282/
https://www.ncbi.nlm.nih.gov/pubmed/31718608
http://dx.doi.org/10.1186/s12885-019-6322-9

Ejemplares similares